Wayne R. Matson

Metabolomic profiling to develop blood biomarkers for Parkinson's disease

Mikhail Bogdanov, Wayne R. Matson, Lei Wang et al. · Brain · 2008 · 401 citations · Full text

Metabolomic Profiling, Neurochemical Biomarkers, Biomarker (Medicine) +16

Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease

Alpaslan Dedeoglu, James K. Kubilus, Thomas M. Jeitner et al. · Journal of Neuroscience · 2002 · 315 citations · Full text

Kynurenine Pathway Measurements in Huntington's Disease Striatum: Evidence for Reduced Formation of Kynurenic Acid

M. Flint Beal, Wayne R. Matson, Kenton J. Swartz et al. · Journal of Neurochemistry · 1990 · 313 citations

Disease Striatum, Neurochemical Biomarkers, Social Sciences +19

Kynurenine pathway abnormalities in Parkinson's disease

T Ogawa, Wayne R. Matson, M. F. Beal et al. · Neurology · 1992 · 312 citations

Neurophysiology, Medicine, Parkinson Disease +13

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

Steven M. Hersch, Sona Gevorkian, Karen Marder et al. · Neurology · 2006 · 310 citations